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Heme is an iron-containing porphyrin ring that serves as a prosthetic group in proteins
that function in diverse metabolic pathways. Heme is also a major source of bioavailable
iron in the human diet. While the synthesis of heme has been well-characterized, the
pathways for heme trafﬁcking remain poorly understood. It is likely that heme transport
across membranes is highly regulated, as free heme is toxic to cells. This review outlines
the requirement for heme delivery to various subcellular compartments as well as possible
mechanisms for the mobilization of heme to these compartments. We also discuss
how these trafﬁcking pathways might function during physiological events involving inter-
and intra-cellular mobilization of heme, including erythropoiesis, erythrophagocytosis,
heme absorption in the gut, as well as heme transport pathways supporting embryonic
development. Lastly, we aim to question the current dogma that heme, in toto, is not
mobilized from one cell or tissue to another, outlining the evidence for these pathways
and drawing parallels to other well-accepted paradigms for copper, iron, and cholesterol
homeostasis.
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INTRODUCTION
Heme is an iron-containing porphyrin that functions as a cofac-
tor in a wide array of cellular processes. Heme is also a major
source of bioavailable iron in the human diet. By the end of
the 20th century, the pathways for heme biosynthesis had been
well elucidated and the structures of many heme-containing pro-
teins have been solved. Indeed, Max Perutz and John Kendrew
were awarded the Nobel Prize in chemistry in 1962 for their crys-
tal structures of hemoglobin and myoglobin (Green et al., 1954;
Kendrew et al., 1958). While the synthesis of heme has been well-
characterized, the pathways for inter- and intra-cellular heme
transport remain poorly understood. This gap in our knowl-
edge is largely due to the inability to uncouple the processes
of heme biosynthesis and heme transport, as well as heme’s
ability to promiscuously bind to proteins. By contrast, great
strides have been made in the ﬁelds of iron and copper traf-
ﬁcking, which have not suffered similar setbacks. Transport
pathways for non-heme iron have been studied for decades and,
all the while, knowledge of heme-iron trafﬁcking has languished.
The title of this review includes a verse from the poem “Kids
Who Die” by the American poet Langston Hughes raising the
possibility that heme too moves like iron in the blood of the
people.
This review aims to (a) outline the biological requirement for
heme trafﬁcking pathways in eukaryotes, including the inability
of heme to efﬁciently traverse lipid membranes and the pres-
ence of hemoproteins in almost all subcellular compartments, (b)
summarize how these putative pathways may participate in var-
ious biological processes, including the synthesis and recycling
of red blood cells (RBCs), intestinal absorption of dietary heme,
embryogenesis, and (c) summarize the evidence for inter-cellular
and inter-tissue transport of heme.
MOVEMENT OF HEME ACROSS MEMBRANES
The terminal step of heme biosynthesis, which occurs in the mito-
chondrial matrix, is the insertion of iron into protoporphyrin IX.
As will be discussed in depth in this article, heme is then targeted
to both soluble and membrane-bound hemoproteins. Hememust
be able to cross membranes, yet also be delivered to soluble pro-
teins in the cytosol. Heme’s amphipathic nature means that it is
able to function in both milieus, but not without the assistance of
partners. Due to the hydrophobicity of the porphyrin ring, heme is
not readily soluble in aqueous solutions. When heme is at neutral
pH and is in the ferrous state it has no net charge, as the negative
charges of the propionate groups balance the positive charges of
the chelated iron.While this form of heme readily inserts into and
diffuses through lipid bilayers, the hydrophilic propionate head
groups hinder the ﬂipping of heme from one leaﬂet to another
(Cannon et al., 1984; Rose et al., 1985; Light and Olson, 1990).
Heme exit from the membrane is inefﬁcient without the presence
of soluble heme-binding proteins (HBPs; Yoda and Israels, 1972).
In addition to the difﬁculties posed by heme’s dual chemical
nature, heme is highly toxic due to its peroxidase activity and
capacity to generate reactive oxygen species combined with its
ability to intercalate into membranes and bind many proteins
non-speciﬁcally. The toxic effects of heme have been reviewed
extensively in mammalian cells and other systems (Vincent, 1989;
Jeney et al., 2002; Oliveira et al., 2002; Kumar and Bandyopad-
hyay, 2005; Chow et al., 2008; Larsen et al., 2012). Thus, even
though heme is able to diffuse into membranes and be extracted
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by HBPs, it is likely that this process would be regulated, as
peroxidation of membrane lipids would result in severe dam-
age, especially during a process such as erythropoiesis, with
each red cell processing the heme required for over 300 million
hemoglobinmolecules. Additionally, many of heme synthesis pre-
cursors and heme breakdown products are also toxic, and thus
careful control of heme synthesis, trafﬁcking, and degradation is
a prerequisite.
Given these chemical and biochemical properties of heme, it is
apparent that a system of transporters and chaperones would be
necessary to efﬁciently and speciﬁcally distribute heme to hemo-
proteins found in various compartments in the cell, all the while
preventing adventitious heme toxicity.
REQUIREMENTS AND MECHANISMS FOR HEME DELIVERY
TO SUBCELLULAR COMPARTMENTS
Hemoproteins can be found in virtually every subcellular com-
partment of eukaryotic cells. In this section we will outline
the requirement for heme delivery from its site of synthesis in
the matrix, to the cytosol, to the secretory compartment, as
well as other possible direct shuttling routes between organelles
(Figure 1).
HEME REQUIREMENTS IN THE MITOCHONDRIA
Most of the mitochondrial respiratory chain complexes rely on
the redox capability of a heme prosthetic group (Table 1). Heme
is present in these complexes in the a, b, or c forms. Heme b is
the most common form of heme. It is the form synthesized by fer-
rochelatase, containing aC2 vinyl group andC8methyl group, and
is attached to proteins via non-covalent coordination of the heme
iron with amino acid side chains (Gonzales and Neupert, 1990;
Hederstedt, 2012). Heme a is modiﬁed from heme b and its por-
phyrins ring contains a C2 hydroxyethylfarnesyl and a C8 formyl
side group (Hederstedt, 2012). Heme c is found covalently linked
to proteins; the two vinyl side chains are converted to thioether
linkages to cysteine residues in the apoprotein (Bowman and Bren,
2008).
The biogenesis and cofactor requirements of the mitochon-
drial respiratory complexes have recently been reviewed, but will
be brieﬂy discussed here with regard to heme transport and traf-
ﬁcking (Kim et al., 2012; Smith et al., 2012; Soto et al., 2012). The
cytochrome bc1 complex (also known as coenzymeQ-cytochrome
c reductase or Complex III) is amulti-subunit protein locatedwith
the other electron transport complexes in the inner mitochondrial
membrane (IMM). The cytochrome bc1 complex includes two
heme b-containing cytochromes as well as a heme c-containing
cytochrome, and interacts with another hemoprotein, the elec-
tron carrier cytochrome c, for the purpose of generating a proton
gradient along the IMM.Cytochrome c is soluble in the intermem-
brane space (IMS) of mitochondria and is found loosely associated
with the IMM, as it carries an electron from the cytochrome
bc1 complex to cytochrome c oxidase (COX). COX (also known
as Complex IV) includes two heme a-containing cytochromes,
which also participate in electron transfer and proton translo-
cation into the IMS. Succinate dehyrogenase (Complex II) also
contains a heme b moiety, which is actually required for sta-
bility of the complex (Lemarie and Grimm, 2009). The heme
b in succinate dehydrogenase may also be involved in electron
transport, but the exact function of this heme remains unclear
(Kim et al., 2012).
In eukaryotes, the cytochrome bc1 complex (Complex III) is
composed of seven or eight nuclear-encoded subunits that func-
tion together with three catalytic core proteins encoded in the
mitochondrial genome (Xia et al., 1997; Iwata et al., 1998; Lange
and Hunte, 2002). Cytochrome b is a membrane-bound core pro-
tein that contains two heme groups, each of which has a unique
redox potential (Zhang et al., 1998). Heme bH, the high poten-
tial heme, is bound in an accessible cavity on the matrix side of
the protein. Heme bL, the low potential heme, is found within
the IMS portion of cytochrome b. Heme bH can be inserted
into cytochrome b without having to traverse a membrane; it
is unknown whether or not a chaperone assists in this process
(Brasseur et al., 1996). It is unclear if heme bL is acquired in the
matrix, or if this heme is inserted in the IMS, thus necessitat-
ing movement of heme across the IMM (Figure 1, Pathway 1).
Cytochrome c1, being nuclear-encoded, is targeted to the mito-
chondria after being translated in the cytosol. Its heme cofactor
is covalently attached in the IMS by the heme lyases Cyc3 and
Cyt2 in yeast or holocytochrome c synthase (HCCS) in mammals
(Bernard et al., 2003). In addition to the heme in cytochrome c1
and possibly the heme bH of cytochrome b, the soluble respira-
tory protein cytochrome c also acquires its heme in the IMS from
HCCS (Bernard et al., 2003).
The biogenesis of COX (Complex IV) in highly conserved in
eukaryotes (Soto et al., 2012). Heme a in COX is bound to the
mitochondrially encoded COX1 subunit. Heme a is synthesized
via the conversion of heme b to the intermediate heme o by the
farnesylation of the C2 position by COX10 (heme o synthase), and
the subsequent oxidation of the C2 methyl side chain to formyl
by COX15 (heme a synthase; Hederstedt, 2012; Soto et al., 2012).
Both COX10 and COX15 are integral membrane proteins located
in the IMM. Studies have indicated that insertion of heme a into
COX1 occurs post-translationally, as early intermediates of the
COX assembly do not contain heme a and are able to form in the
absence of heme a biosynthesis (Khalimonchuk et al., 2010). This
is in contrast with later intermediates, which do not form without
the presence of heme a. It remains unclear if heme chaperones
exist to shuttle heme b from its site of synthesis to COX10, or
to deliver heme a to the COX1 subunit. By contrast, multiple
mitochondrial chaperones, including COX17, SCO1, and COX11,
have been shown to act as chaperones for delivery of copper to the
COX complex [Also reviewed in Soto et al. (2012)].
In addition to the respiratory chain complex proteins, another
cytochrome, cytochrome P450 side chain cleavage enzyme (also
known as CYP11A1), is also found in the mitochondrial matrix.
This enzyme is expressed in steroid-synthesizing tissues such as
the brain and adrenal glands and functions to convert cholesterol
to pregnenolone, a precursor for mineralocorticoids, glucocor-
ticoids, androgens, and estrogens (Simpson and Boyd, 1967).
CYP11A1 catalyzes this ﬁrst step in steroid-synthesis by initiat-
ing three sequential monooxygenase reactions of the cholesterol
side chain: hydroxylation of C20 and C22 and then cleavage the
C20–C22bond to generate the steroidprecursor pregnenolone and
isocaproic aldehyde. While the crystal structures of both bovine
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FIGURE 1 | Presumptive pathways for delivery of heme to
hemoproteins in eukaryotic cells: (1) Heme transport across the
inner mitochondrial membrane, (2) Heme transport across the outer
mitochondrial membrane, (3) direct heme trafﬁcking from the
mitochondria to the ER via mitochondria-associated membranes
(MAMs), (4) trafﬁcking of heme from mitochondria to
endolysosomal compartments via mitochondrial-derived vesicles
(MDVs), (5) transport of cytosolic heme into the secretory pathway
by a heme exporter, (6) trafﬁcking of heme in ER/Golgi to
endolysosomal compartments, (7) import of heme into the cell via
an endocytic pathway, and (8) import of heme via a plasma
membrane heme importer.
and humanCYP11A1 have recently been solved, nothing is known
regarding how the heme cofactor is inserted into this important
hemoprotein (Mast et al., 2011; Strushkevich et al., 2011).
HEME REQUIREMENTS IN THE CYTOSOL
While heme moves from the mitochondrial matrix into the IMS
for insertion into particular cytochromes, heme must also exit
the mitochondria for insertion into hemoproteins which acquire
heme in the cytosol (Table 1). The most well known cytosolic
hemoproteins are the gas-binding globins, including hemoglobin,
myoglobin, neuroglobin, and cytoglobin. Adult hemoglobin con-
sists of two α and two β chains, each bound to amolecule of heme.
Hemoglobin can be generated in vitro (for example, by heterol-
ogous expression in Escherichia coli, or by recombining puriﬁed
apo-hemoglobin with heme) indicating that no speciﬁc chaper-
one is required for heme insertion. Because of its asymmetric
side chains, each heme can be incorporated into hemoglobin in
two orientations. The term “heme disorder” refers to mixtures of
these two orientations within a subset of hemoglobin molecules
(Brown, 1976). Interestingly, the amount of heme disorder differs
between hemoglobin synthesized in vivo or in vitro (Santucci et al.,
1990). This is a possible indication that stereoselective insertion of
heme into hemoglobin occurs, although the mechanism for this
phenomenon remains unclear.
Other categories of hemoproteins that acquire their heme in
cytosol include nitric oxide (NO) synthases and the soluble guany-
lyl cyclases (a NO receptor), the nuclear HBPs Hap1p, DGCR8,
mPer2, Bach1 and Rev-erb-α, as well as the soluble form of
cytochrome b5. Even P450 cytochromes, the most well known
hemoproteins in the ER, are anchored in the ER membrane with
their heme-containing globular domain facing the cytosol (Black,
1992; Avadhani et al., 2011). Thus, cytochrome P450 proteins
likely acquire their heme from the cytosolic face of the membrane.
HEME DELIVERY TO CYTOSOLIC PROTEINS
Cytosolic hemoproteins can acquire their heme from two possible
sources: heme synthesized de novo in the mitochondria, or heme
imported from outside the cell. Heme synthesized in mitochron-
dria exits the active site pocket of ferrochelatase, which faces the
matrix side of the IMM (Wu et al., 2001). Exactly how heme exits
ferrochelatase remains unknown. It is possible that this heme
immediately intercalates into the IMM or is actively transported
across the IMM and then is removed into the IMS by a heme-
binding chaperone and then moved across the OMM by a high
afﬁnity heme transporter (Figure 1, Pathways 1 and 2).
The sole mitochondrial heme exporter identiﬁed to date is
the mitochondrial isoform of Flvcr1 (Quigley et al., 2004; Keel
et al., 2008). Flvcr1, a member of the major facilitator superfamily
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Table 1 | List of selected eukaryotic hemoproteins.
Hemoprotein Function Subcellular localization
Succinate dehydrogenase (Complex II) Electron transport Mitochondrial (IMM)
Cytochrome bc1 complex (Complex III) Electron transport Mitochondrial (IMM)
Cytochrome c Electron transport Mitochondrial (IMS)
Cytochrome c oxidase (Complex IV) Electron transport Mitochondrial (IMM)
CYP11A1 Steroid synthesis Mitochondrial (matrix)
Hemoglobin Gas-binding Cytosolic
Myoglobin Gas-binding Cytosolic
Neuroglobin Gas-binding Cytosolic
Cytoglobin Gas-binding Cytosolic
Nitric oxide (NO) synthase NO signaling Cytosolic
Soluble guanylyl cyclases NO and Ca2+ signaling Cytosolic
Hap1p Transcription factor Nuclear
Bach1 Transcription factor Cytosolic/nuclear
Rev-erb-α Transcription factor Nuclear
DGCR8 miRNA processing Nuclear
mPer2 Circadian rhythm Cytosolic/nuclear
Cytochrome b5 Electron carrier Cytosolic
P450 cytochromes Oxidation of metabolites and xenobiotics ER membrane (active site is cytosolic)
Prostaglandin synthases (COX1 and COX2) Autocrine/paracrine signaling ER
Myeloperoxidase Microbicide Lysosome-like azurophil granules
Catalase Antioxidant Peroxisomes
Thyroperoxidase Thyroid hormone synthesis Plasma membrane
Ferric reductase Iron transport Plasma membrane
Lactoperoxidase Microbicide Secreted
Ligninase Nutrient breakdown Secreted
Heme-containing chloroperoxidase Haloperoxidase Secreted
Peroxidasin Extracellular matrix synthesis Secreted
HRG-3 Heme mobilization Secreted
Rhodnius heme-binding protein (RHBP) Heme mobilization Secreted
of transporters, was initially identiﬁed as a plasma membrane
heme exporter. Cats infected with feline leukemia virus, sub-
group C (FeLV-C) develop aplastic anemia due to failure of
erythroid differentiation of burst-forming units-erythroid (BFU-
E) to colony-forming units-erythroid (CFU-E). Viral infection of
these erythroid progenitors interferes with and possibly downreg-
ulates cell surface expression of the viral receptor, Flvcr1 (Quigley
et al., 2004). Early experiments showed that Flvcr1 could mediate
cellular efﬂux of either exogenously added or endogenous heme
(Quigley et al., 2004; Yang et al., 2010). Mice lacking Flvcr1 die
either at E7.5 or between E14.5 and E16.5. Similar to Hmox1,
Flvcr1 is expressed in the yolk sac, ectoplacental cone, and pla-
centa at E7.5. Thus the early death of Flvcr1 null embryos is likely
due to heme accumulation within cells, although it is also possible
that Flvcr1 is required for delivery of maternal heme. Keel et al.
(2008) conclude that Flvcr1 null embryos die at the later stage due
to impaired erythropoiesis. Red cells in these mice are blocked at
the proerythroblast stage, in keeping with feline infection model
as well as in vitro studies showing that K562 cells fail to differen-
tiate when infected with FeLV-C (Keel et al., 2008). Interestingly,
Flvcr1 mice exhibit cranial and limb deformities which are not
usually associated with lack of deﬁnitive erythropoiesis, indicating
additional functions for Flvcr1 in development.
Recently, Chiabrando et al. (2012) identiﬁed a mitochondrial
isoform of Flvcr1, termed Flvcr1b.While Flvcr1a encodes a plasma
membrane-localized transporter, Flvcr1b contains an alternative
transcription start site, resulting in a shortened amino termi-
nus containing a mitochondrial targeting signal. Depletion of
Flvcr1b in HeLa cells results in accumulation of mitochondrial
heme, indicating that Flvc1b plays a role in heme export from
the mitochondria (Chiabrando et al., 2012). Speciﬁc deletion of
Flvcr1a in mice resulted in death between E14.5 and birth due
to hemorrhage, edema, and skeletal abnormalities; however, ery-
thropoiesis in these mice appeared to be normal and fetal liver
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cells from these mutant mice were able to repopulate irradiated
wild type mice (Chiabrando et al., 2012). The authors conclude
that Flvcr1a null mice suffer mainly from the loss of a plasma
membrane heme exporter. Heme overload in endothelial cells
leads to a loss of vascular integrity resulting in the hemorrhage,
edema, and skeletal defects observed in these mice. The authors
attribute the lethality of the original Flvcr1 knockout mice to lack
of heme export from the mitochondria by Flvcr1b, as mice lack-
ing Flvcr1a but not mitochondrial Flvcr1b appear to have normal
erythropoiesis.
Numerous questions regarding heme exit from the mitochon-
dria remain unanswered. It is not yet known if Flvcr1b resides on
the mitochondrial IMM or OMM, with the possibility of another
distinct mitochondrial heme exporter yet to be found. It is also
unclear whether Flvcr1b is actually located within the mitochon-
dria or is associated withmembranes that tether themitochondria
to other organelles. If mitochondrial heme export is indeed atten-
uated, how do Flvcr1−/− embryos even survive until E14.5? Does
Flvcr1b function in speciﬁc cell types? Yeast do not appear to
have an obvious FLVCR homolog, yet are able to export heme
from themitochondria; what alternatemechanisms exist formito-
chondrial heme export? No speciﬁc heme chaperones have been
found to bind heme in the IMS, or to deliver heme to cytosolic
hemoproteins. A number of cytosolic HBPs have been identiﬁed,
including 22- and 23-kDa HBPs and the HBP homolog, SOUL
(Iwahara et al., 1995; Taketani et al., 1998; Zylka and Reppert,
1999). These proteins could serve as “sponges” for heme exiting
the mitochondria, simultaneously protecting the cell from heme’s
cytotoxicity and also delivering heme to target hemoproteins. It
remainsunclearwhethermultiple non-speciﬁcporphyrin-binding
molecules perform the role of chaperoning heme in the cytosol,
or if there are heme- and/or hemoprotein-speciﬁc pathways.
Presumably, heme imported into the cell, rather than solely
heme exported from themitochondria, could be bound by cytoso-
lic heme chaperones and delivered to newly forming hemoproteins
(Figure 1, Pathway 8). As such, plasmamembrane heme importers
could also be sources of heme for these enzymes. A discussion of
putative heme importers can be found in the accompanying review
of heme in pathophysiology by Chiabrando et al. (2014). Here we
will focus on the heme importer, Hrg1.
The heme-responsive paralogs, hrg-1 and hrg-4, were ini-
tially discovered as transmembrane domain-containing permeases
upregulated in response to heme deﬁciency in Caenorhabdi-
tis elegans (Rajagopal et al., 2008). HRG-4 is localized to the
apical plasma membrane of the worm intestine and serves to
import dietary heme into the animal (Rajagopal et al., 2008;
Yuan et al., 2012). HRG-1 localizes to lysosome-like vesicles
in the intestine, and serves to mobilize heme stored in these
compartments (Rajagopal et al., 2008; Yuan et al., 2012). While
hrg-4 does not appear to have homologs in other species, hrg-1
homologs, also called solute carrier 48 A1 (SLC48A1) proteins,
have been found in diverse organisms, including Leishmania
spp., zebraﬁsh, and mammals (Rajagopal et al., 2008; Huynh
et al., 2012; Yuan et al., 2012; White et al., 2013). Knockdown
of hrg-1 in zebraﬁsh leads to anemia, although the genetic eti-
ology for the anemia phenotype is not known. Transport of
heme by hrg-1 and hrg-4 has been demonstrated directly using
electrophysiological currents in Xenopus oocytes, and indirectly
using heme-dependent growth of C. elegans and Saccharomyces
cerevisiae or uptake of heme analogs as indicators of heme
import.
Mammalian Hrg1 has been shown to be expressed widely, with
the highest expression in the brain, heart, kidney, and muscle,
with some expression in the placenta and intestine (Rajagopal
et al., 2008). Hrg1 has been linked to a possible role in cancer
progression, as its interaction with V-type ATPases is associated
with changes in endocytic trafﬁcking, extracellular acidiﬁcation,
altered glucose metabolism, and matrix metalloprotease activ-
ity (O’Callaghan et al., 2010; Fogarty et al., 2013). Depletion of
Hrg1 in MCF7 cells resulted in decreased invasiveness and migra-
tion capabilities in these cells. Hrg1 has also been found to be a
target of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the
antioxidant response transcription factor (Campbell et al., 2013).
In independent studies, human Hrg1 colocalized with Lamp1
in lysosomes, and Hrg1 is found on the erythrophagolysosome
in macrophages during RBC heme-recycling (Delaby et al., 2012;
White et al., 2013). Hrg1 has been shown to mediate hemoglobin-
derived heme export from this compartment in macrophages and
this process will be discussed in Section “Heme Transport during
Erythropoiesis.”
HEME REQUIREMENT IN THE SECRETORY PATHWAY
A variety of hemoproteins function in multiple components of
the secretory pathway (Table 1). Lysosomal, peroxisomal, plasma
membrane-targeted and secreted hemoproteins are folded and
processed within the ER and Golgi, and thus the cell must have a
means of transferring heme from the mitochondria into various
subcellular membrane-bound compartments. These hemopro-
teins include the well known prostaglandin synthases (COX1
and COX2) in the ER, myeloperoxidase (MPO) in lysosome-like
azurophil granules, eosinophil peroxidase in eosinophil granules,
catalase in peroxisomes, the plasma membrane proteins thyroper-
oxidase and ferric reductase, as well as numerous secreted proteins
including lactoperoxidase, fungal ligninase and chloroperoxidase,
C. elegans hrg-3, Drosophila peroxidasin, and RHBP (Rhod-
nius heme-binding protein) in the blood-feeding insect Rhodnius
prolixus.
Almost nothing is known regarding how these proteins obtain
their heme cofactors. Given that the secretory and endocytic path-
ways are somewhat contiguous,withprotein and lipid components
being shuttled from location to another, it is feasible that heme
need only be transported across a singlemembrane into the lumen
of one such compartment, and from there can be mobilized to its
intended destination by carrier proteins (Figure 1, Pathways 3–
7; De Matteis and Luini, 2008). For example, heme exiting the
mitochondria may be transported into the ER, and from there be
inserted into its target hemoprotein during protein folding, fol-
lowing which the protein can then trafﬁc to its target organelle.
It is also possible that one or many heme chaperones exist in the
secretory pathway for delivery of heme to hemoproteins in their
destination compartments. The fact that no mechanism for tar-
geting heme to the secretory pathway has been discovered suggests
that multiple mechanisms exist and can compensate for loss of a
single such constituent.
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In contrast tomany hemoproteins in the secretory pathway, the
maturation process of MPO has been well-characterized. MPO
is a microbicidal protein generated by myeloid cells; its ability
to chlorinate substrates enables it to generate hypochlorous acid
from hydrogen peroxide [Reviewed in Klebanoff et al. (2013)].
This hemoprotein is extensively processed as it moves through
the ER and Golgi; a single 80 kDa apoproMPO peptide is con-
verted to a glycosolated, heme-containing protein consisting of a
59 kD heavy subunit and a 15.5 kD light subunit that is targeted
for secretion in its pro-form or for storage in azurophil granules
as a mature protein [Reviewed in Hansson et al. (2006)]. Early
studies showed that disruption of the Golgi stacks with brefeldin
A treatment resulted in MPO that is able to acquire heme but
was improperly processed and remained in the pro-form (Nauseef
et al., 1992). Moreover, treatment of the cells with succinyl acetone
to inhibit heme synthesis also resulted inMPOthatwas improperly
processed, while the processing and trafﬁcking of other lysosomal
proteins remained unchanged. The authors concluded that cleav-
age of MPO into its mature heavy and light subunits occurred
in a post-ER compartment, that insertion of heme occurred in
the ER, and that heme insertion was required for further pro-
cessing. Further support for these conclusions was provided by
mutants, such as the R569W MPO mutant which is unable to
acquire heme and remains trapped in an apo-form in the ER (a
result suggesting that heme insertion is necessary for ER exit), and
the Y173C MPO mutant, which does acquire heme but is unable
to exit the ER (suggesting that heme insertion is mediated within
the ER; Nauseef et al., 1994; DeLeo et al., 1998). The aberrant
processing of these mutant forms of MPO is especially informa-
tive, as these results lack the confounding effects of brefeldin A
treatment.
The ER chaperones calreticulin and calnexin, which perform
quality control during the folding of glycoproteins, unsurpris-
ingly bind MPO as it is being folded and processed in the ER.
Interestingly, these two similar proteins are able to distinguish
between processed and unprocessed MPO, in a manner that
likely enables sequential interaction of MPO with both chap-
erones. Calreticulin appears to bind apoproMPO preferentially,
while calnexin binds both apoproMPO and the heme-containing
apoMPO (Nauseef et al., 1998). It is possible that calnexin plays
a role in the insertion of heme into MPO as it binds to both
the apopro- and heme-containing pro- versions of the protein.
Interestingly, one study showed that overexpression of calnexin
in the fungus Aspergillus niger resulted in increased produc-
tion of a secreted hemoprotein, manganese peroxidase, but only
in the absence of heme supplementation in the media. This
suggested that calnexin can function as a protein chaperone capa-
ble of enhancing holo manganese peroxidase assembly (Conesa
et al., 2002). Studies have shown that palmitoylation of calnexin
increased its localization to mitochondrial-associated membranes
(MAMs) of the ER (Lynes et al., 2012) – a location where heme
could, in principle, enter the ER (as discussed in Section “Mech-
anisms for Heme Delivery to the Secretory Pathway”). It has very
recently been shown that palmitoylation switches calnexin froman
ERp47-interacting quality control molecule to a MAM-associated
regulator of ER-mitochondrial crosstalk and two proteomic analy-
ses of MAMs have independently detected the presence of calnexin
(Lynes et al., 2013). While it is tempting to speculate that calnexin
couldmoonlight as a chaperone for heme entering the ER from the
mitochondria, the matter remains a mystery until further studies
are performed.
MECHANISMS FOR HEME DELIVERY TO THE SECRETORY PATHWAY
Theoretically, there are a number of ways heme could enter the
lumen of the secretory pathway. Heme released from the mito-
chondria could pass through the cytosol to be actively transported
across the membrane of any subcellular organelle, (although no
such transporter has yet been identiﬁed; Figure 1, Pathway 5).
Heme imported into the cytosol could be moved into the secre-
tory pathway in this manner as well. Heme entering the cell
through an endocytic process (i.e., heme bound to hemopexin
internalized via the low-density lipoprotein receptor-related pro-
tein LRP/CD91) could be trafﬁcking to such compartments, with
the possible participation of a chaperone to sequester and guide
heme to its destination (Figure 1, Pathway 7). One appealing pos-
sibility is that nascent heme synthesized in themitochondria could
be shielded by membranes using vesicular trafﬁcking or by enter-
ing the secretory pathway through direct contacts between the ER
and mitochondrial membranes (Figure 1, Pathways 3 and 4).
Contacts between ER and mitochondrial outer membranes
were observed over 40 years ago (Ruby et al., 1969; Lewis
and Tata, 1973). Jean Vance coined the term MAM when she
identiﬁed a functional relationship between these organelles to
exchange phospholipids (Vance, 1990). With better subcellular
fractionation techniques, and the advent of ﬂuorescent imag-
ing, especially the recent development of superresolution imaging,
dynamic microdomains where mitochondrial membranes are
tethered to ER membranes have been observed. These include
the ER-mitochondrion encounter structure (ERMES) in yeast and
the previously mentioned MAMs, found in plants and animals
(Kornmann et al., 2009, 2011). These structures are involved in
facilitating the transport of ionic calcium into the mitochondria,
regulation of autophagy and apoptosis, and, more relevant to this
review, the trafﬁcking of lipids (Michel and Kornmann, 2012).
The transport of phosphatidylserine from the ER to mitochon-
dria has been demonstrated and it is hypothesized that other
lipids are mobilized between these two organelles in a similar
manner. Interestingly, two independent proteomic analyses of
MAMs have detected the presence of coproporphyrinogen III oxi-
dase, ferrochelatase, HBP 1, and heme oxygenase 2 (Poston et al.,
2011; Zhang et al., 2011). It is intriguing to postulate that these
ER-mitochondria connections could be an axis for heme transport
(Figure 1, Pathway 3).
Another possible mechanism for the trafﬁcking of heme from
the mitochondria to other organelles is the use of mitochondrial-
derived vesicles (MDVs), which have been shown to trafﬁc to both
peroxisomes and lysosomes (Figure 1, Pathway 4; Neuspiel et al.,
2008; Schumann and Subramani, 2008). Initially, 70–100 nm vesi-
cles were shown to deliver speciﬁc mitochondrial cargo proteins
to peroxisomes. Other vesicles were later observed carrying cargo
to lysosomes in response to increase in cellular oxidative stress
(Soubannier et al., 2012; McLelland et al., 2014). As the processes
of heme synthesis, mitochondrial respiration, and responding to
oxidative stress are innately coupled by their shared metabolic
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pathways and mitochondrial location in the cell, it is possible to
speculate that heme may be mobilized to these organelles via this
mechanism.
HEME TRAFFICKING AND IRON METABOLISM
HEME TRANSPORT DURING ERYTHROPOIESIS
During deﬁnitive erythropoiesis, hematopoietic progenitors dif-
ferentiate into mature RBCs. In the fetal liver or bone marrow,
hematopoietic stem cells develop into early BFU-E progenitors
and then into CFU-E progenitors, which are both deﬁned by
their capacity to form cell clusters in vitro [Reviewed in Palis
(2014)]. These progenitor cells progress into erythroid pre-
cursors, which develop from early proerythroblasts (ProE), to
basophilic erythroblasts (Baso), to polychromatophilic erythrob-
lasts (PolyE), and ﬁnally become orthochromatic erythroblasts
(OrthoE). Orthochromatic erythroblasts enucleate to form retic-
ulocytes which move out into circulation and after about 24 h
become mature RBCs. The erythroid precursors develop from
the ProE stage to the OrthoE stage in a unique niche called
the erythroblastic island. This niche consists of a central nurse
macrophage surrounded by a ring of developing RBC precursors.
It is at this stage where heme and hemoglobin synthesis rapidly
increase, as the cells draw near their fate as RBCs (Figure 2A).
Nurse macrophages maintain physical contacts with erythrob-
lasts as they differentiate. They phagocytose the nuclei extruded
by red cells, and are thought to enhance differentiation in some
capacity. This specialized niche has been shown to be dispensable
for erythropoiesis under steady state conditions (Chow et al., 2013;
Ramos et al., 2013). However, in response to anemia, erythro-
poiesis expands from the bonemarrow to the spleen and liver, with
increased iron mobilization and RBC formation. Recent studies
have shown that nurse macrophages play a regulatory role during
stress erythropoiesis. Depletion of macrophages does not alter the
numbers or proﬁles of erythroid cells in normal mice. However,
mice with phlebotomy-induced anemia showed a decreased abil-
ity to recover from this state in the absence of macrophages, as
shown by decreased red cell formation compared to control mice.
Interestingly, the loss of thesemacrophages ameliorated symptoms
FIGURE 2 | Heme transport pathways relevant during major
physiological events. Unknown pathways are indicated with a (?).
(A) Putative delivery of heme from a central nurse macrophage to developing
erythroblasts. (B) Pathways for iron and heme-recycling during
erythrophagocytosis. Hrg1 imports heme into the cytoplasm from the
erythrophagolysosome. A portion of heme is (Green et al., 1954) degraded by
Hmox1 and iron released is either stored in ferritin (Ftn) or exported by
ferroportin (Fpn; Kendrew et al., 1958). Some heme may be exported via a
plasma membrane heme transporter such as Flvcr1a, or (Cannon et al., 1984)
used by the cell for incorporation into hemoproteins. (C) Pathways for dietary
heme uptake by enterocytes. There is evidence for an intestinal heme import
across the apical membrane of enterocytes, although it is unclear whether
this pathway utilizes membrane-bound transporters or endocytic uptake or
both mechanisms. Most heme is mobilized into the circulation as iron after
degradation by Hmox1, but heme may, in principle, also directly enter the
circulation.
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of both polycythemia vera and β-thalassemia, as both diseases
involve a pathological increase in RBC production (Hashimoto
et al., 2013; Ramos et al., 2013).
Some have suggested that nurse cells may contribute nutri-
ents, possibly even iron or heme itself, to developing erythroblasts
[Reviewed in Manwani and Bieker (2008)]. Under steady state
conditions, the contribution of nurse macrophages is clearly dis-
pensable for normal erythropoiesis; however, under stress erythro-
poiesis, the nutritional contribution of nurse macrophages may
play a more important role. Developing erythroblasts co-cultured
with macrophages in transwells showed a marked decrease in the
beneﬁcial effects that physical contact between the two cell types
normally provides (Ramos et al., 2013). This result indicates that
direct contact between the two cell types is required to maximize
the positive effect of macrophages, but does not rule out a role for
secreted factors.
It was reported that ferritin molecules were localized between
the membranes of the central nurse macrophage and developing
erythroblasts, and that this ferritin is taken up the erythroblasts by
micropinocytosis (Policard and Bessis, 1962). However, the orig-
inal source of this ferritin remains a mystery. It is possible that a
portion of heme and/or iron within a maturing red cell is derived
from inter-cellular transport from macrophages to support the
initial stages of hemoglobinization, especially under stress condi-
tions. In support of this hypothesis, heme importers Hrg1 and
exporters Flvcr1 are both expressed in red cells and macrophages.
HEME MOBILIZATION DURING ERYTHROPHAGOCYTOSIS
Much like the birth of RBCs, the ﬁnal moments of a red cell are
spent in the care of a macrophage. Human RBCs have a lifespan of
about 120 days, afterwhich they become senescent and are recycled
by macrophages of the reticuloendothelial system (RES) found in
the spleen and liver [Reviewed in Knutson and Wessling-Resnick
(2003)]. This process – phagocytosis of RBCs and the breakdown
of billions of molecules of hemoglobin – is termed erythrophago-
cytosis (EP; Figure 2B). EP is essential, as the bulk of iron required
for the synthesis of new hemoglobin (∼25 mg/day) derives from
RBC recycling (Bratosin et al., 1998). By contrast, only about 1 mg
per day of dietary iron contributes to erythropoiesis. Heme oxyge-
nase 1 (Hmox1) plays a vital role in this process, freeing iron from
its protoporphyrin ring, and enabling the release of this iron for
reuse. Hmox1−/− mice suffer from anemia, reduced serum iron,
and accumulation of iron in the spleen and liver, as the ability
to recycle heme-iron in these mutants is almost completely crip-
pled (Poss and Tonegawa, 1997). In vitro experiments showed that
Hmox1−/− macrophages die when fed RBCs, and that splenic and
liver macrophages are absent in Hmox1−/− mice (Kovtunovych
et al., 2010).
Heme extracted from RBCs was postulated by some to be
degraded by Hmox1 in the phagolysosome (Beaumont and
Canonne-Hergaux, 2005). Subsequently, the newly released iron
was either stored in ferritin (Ftn) or returned to the circulating
pool of iron via the cellular heme exporter, ferroportin (Fpn). A
major problem with this model is that Hmox1, while localizing to
the ER via a C-terminal transmembrane segment, has been shown
to be oriented with its active site facing the cytosol (Gottlieb et al.,
2012). Furthermore, the pH optimum for heme catabolism by
Hmox1 is closer to physiological pH (pH 7.6) than lysosomal pH,
and maximal Hmox1 activity requires the presence of biliverdin
reductase (Liu and Ortiz de Montellano, 2000; Reed et al., 2010).
Studies have shown that heme oxygenases are not present on the
phagolysosomal membrane, even though this membrane is par-
tially derived from the ER (Delaby et al., 2012). Thus Hmox1
likely does not have access to heme within the phagolysosomal
compartment, suggesting that heme must exit this membrane
compartment for degradation.
Hrg1, which has been shown to localize to endocytic compart-
ments inmammalian cells, has recently been reported to transport
heme across the phagolysosomal membrane (Delaby et al., 2012;
White et al., 2013). Hrg1 is expressed in RES macrophages and
is upregulated at both the mRNA and protein level in the pres-
ence of heme and during EP. This was true in both an ex
vivo model using bone-marrow derived macrophages (BMDMs)
treated with damaged RBCs, as well as in the livers of mice
treated with either heme, damaged RBCs, or the hemolysis agent
phenylhydrazine (White et al., 2013). During EP, Hrg1 accu-
mulates on the membrane of the phagolysosome (White et al.,
2013), and when Hrg1 is depleted by siRNA, BMDMs are inca-
pable of upregulating the machinery normally required to deal
with the inﬂux of heme and iron (including Hmox1, Ftn, Fpn,
and Hrg1 itself) indicating a lack of heme export from the
phagolysosome.
Interestingly, a polymorphism of Hrg1 (P36L mutation) asso-
ciated with anemia in four patients was shown to be defective in
heme export in both a yeast model of heme transport, and during
EP in BMDMs (White et al., 2013). These experiments used a het-
erogously expressedhemoprotein reporter, horseradish peroxidase
(HRP), targeted to the Golgi to interrogate cellular heme availabil-
ity and showed that heme derived from recycled RBCs could be
incorporated into an apohemoprotein by assaying HRP activity
in BMDMs during EP. While further experiments are required
to deﬁnitively show that the increased HRP activity was due to
incorporation of heme recycled in toto, rather than endogenously
synthesized heme, these experiments suggest that not all heme lib-
erated during EP is degraded via Hmox1, and that a portion can
be reused by the cell.
DIETARY HEME TRANSPORT AND ENTEROCYTE METABOLISM
Heme is themost bioavailable formof iron in the diet, as ferric iron
can form insoluble ferric hydroxide or hydroxyl-iron dimers in the
intestine and the uptake of soluble iron is inhibited by iron chela-
tors found in certain foods [Reviewed in West and Oates (2008)].
Early studies using radiolabeled heme showed that heme enters
enterocytes, where most of it is degraded and exported as iron
to the circulation (Figure 2C; Walsh et al., 1955; Weintraub et al.,
1965; Brown et al., 1968). Interestingly, these early studies showed
that unlike uptake of inorganic iron, heme uptake is not signiﬁ-
cantly upregulated during iron deﬁciency (Turnbull et al., 1962).
Later studies showed that this process was mediated by a recep-
tor or transporter, as it was pH dependent, saturable, and that its
activity was lost in the presence of trypsin (Grasbeck et al., 1979,
1982; Galbraith et al., 1985;Majuri, 1989; Noyer et al., 1998). Stud-
ies using zinc mesoporphyrin showed that uptake was inducible
with heme depletion and speciﬁc to certain cell types, as it was
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observed in intestinal Caco-2 and I-407 cells and hepatic HepG2
cells but not in mouse ﬁbroblasts (Worthington et al., 2001).
A recent study analyzed the uptake of 58Fe-heme versus a non-
heme iron source (57FeSO4) in pregnant women (Young et al.,
2012). Cord blood from neonates taken at time of delivery con-
tained signiﬁcantly more 58Fe than 57Fe. This study suggests that
iron absorbed in the form of heme contributes substantially to
body iron stores presumably because dietary heme-iron is more
bioavailable for intestinal absorption and therefore is preferentially
delivered to the developing fetus. However, it is unclear whether
the 58Fe detected is due to degradation of dietary heme within
the intestine or, more provocatively, that a portion of ingested
58Fe-heme is delivered intact to the fetus. To differentiate between
these possibilities, similar studies must be undertaken using heme
labeled in the porphyrin ring.
The relative contributions of receptor-mediated endocytosis
versus membrane transport to intestinal heme uptake remain
unclear. Early studies of heme uptake in dogs and rats used
diaminobenzidine (DAB) staining to visualize intact heme taken
up into intestinal epithelial cells (Parmley et al., 1981; Wyllie and
Kaufman, 1982). Heme was shown to accumulate on the sur-
faces of microvilli and in endosomal compartments in the apical
cytoplasm, evidence for uptake via an endocytic process. How-
ever, these studies do not exclude the possibility that heme is also
directly transported across the apical plasma membrane, as heme
accumulating in the cytosol may not be sufﬁciently concentrated
to visualize with DAB staining.
It was reported that heme carrier protein 1 (HCP1) was an
intestinal heme importer (Shayeghi et al., 2005). Later, biochemi-
cal and genetic studies determined that HCP1 was a high afﬁnity
folate transporter, as it was capable of mediating folate transport
and loss-of-function mutations in human patients were associ-
ated with hereditary folate malabsorption (Qiu et al., 2006). Qiu
et al. (2006) note that folate supplements completely corrected any
hematological defects associated with folate deﬁciency, indicat-
ing that this syndrome was not caused by defective heme uptake.
An analysis of transport by HCP1, now termed HCP1/proton
coupled folate transporter (PCFT), supported the conclusion
that the physiological substrate of HCP1/PCFT is folate, though
the protein may have weak heme transport activity. Thus, the
mechanism (or mechanisms) of intestinal heme import remains
unknown.
It may be useful to apply our knowledge of better-characterized
paradigms of intestinal import to study intestinal heme uptake.
For example, does heme traverse enterocytes via transcytosis, in a
manner similar to vitamin B12, which is endocytosed in clathrin-
coated vesicles, trafﬁcked to lysosomes, and then secreted from
the basolateral intestinal membrane? Does heme, like iron, utilize
a transcellular trafﬁcking route, making use of apical importers
and basolateral exporters for directed movement into the body?
Additionally, early studies showed that the bulk of heme exported
from the intestine into the portal circulation is in the form of free
iron released from degraded heme. What if heme is not exported
from the enterocytes via blood? It is worth noting that cholesterol,
another bulky, hydrophobic molecule, is exported into the lymph
after being absorbed in the intestine (Abumrad and Davidson,
2012).
HEME TRAFFICKING DURING EMBRYOGENESIS
It has long been known that metal homeostasis plays a vital role in
embryonic andpost-embryonic development (Kambe et al., 2008).
For example, mouse pups from iron- or copper-depleted dams
experience developmental and neurological abnormalities whose
severity is dependent on the timing and extent of the mater-
nal deﬁciency. A number of metal transporters are embryonic
lethal when targeted for gene knockout. There are two separate
but interconnected processes that should be taken into account
when discussing this topic: (a) metal transport within embryonic
cells as pluripotent cells grow and differentiate into tissues; and
(b) maternal transfer of metals to developing embryos that lack
an independent dietary source for these nutrients. We will con-
sider the roles of both modes of transport with regards to heme
homeostasis.
The respective phenotypes of the Flvcr1 and Flvcr1a knockout
mice provide some insight into the role of heme transport dur-
ing embryogenesis. As previously mentioned, Keel et al. (2008)
report that homozygous Flvcr1 knockout pups (which lack both
the mitochondrial and plasma membrane isoforms of Flvcr1) are
found dead at either E7.5 or later at E14.5–E16.5. The authors infer
from this observation that Flvcr1 is required for deﬁnitive erythro-
poiesis (which begins at∼E12) and not embryonic erythropoiesis.
In support of this, they mention that yolk sac-derived erythrob-
lasts donot express Flvcr1 and appear normal inFlvcr1−/− mice. If
the cause of mortality in Flvcr1−/− mice is defective heme export
from the mitochondria, then we must wonder about the source
of heme used for embryonic erythropoiesis. It may be that this
heme is maternally derived via one or more heme importers in the
early embryo. It is known that homozygous ferrochelatase knock-
out embryos can be detected at the E3.5 preimplantation stage,
but are reabsorbed and undetectable at E9–E10 – a phenotype also
observed for uroporphyrinogen decarboxylase knockout animals
(Phillips, personal communication; Magness et al., 2002; Phillips
et al., 2007). Presumably, the ferrochelatase null phenotype should
overlap with the Flvcr1−/− phenotype, as both would cause heme
deﬁciency in the cell. The greater severity of the ferrochelatase
mutant hints that, in the Flvcr−/− mice, a small portion of heme
can exit the mitochondria in an Flvcr1-independent manner to
sustain life for a few extra days.
Interestingly, deletion of the Flvcr1a isoformalso causes embry-
onic lethality (Chiabrando et al., 2012). This lethality, due to
hemorrhages, edema, and skeletal malformations, is observed
later during development, usually between E14.5 and birth.
Chiabrando et al. (2012) speculate that many of these defects, also
observed in mice with defects in endothelial integrity, are due
to heme buildup within endothelial cells leading to widespread
oxidative stress and hypoxic conditions in developing embryos.
Interestingly, Flvcr1b is upregulated in these mice, presumably
leading to increased cytoplasmic heme as evidenced by increased
levels of Hmox1, though its activity is insufﬁcient to rescue the
embryos. Thus, plasma membrane heme export is an essential
regulator of heme homeostasis during development.
While intercellular and intracellular heme transport are critical
during embryogenesis,maternal transfer of heme to offspringmay
also play a critical role in embryonic development. This process has
been demonstrated in C. elegans, where the small peptide HRG-3
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serves as a chaperone for heme delivery to developing embryos
and extraintestinal tissues (Chen et al., 2011). When the worm is
heme deprived, expression of hrg-3 in the intestine is upregulated
>300-fold. HRG-3 is processed in the secretory pathway into a
45-amino acid chaperone which binds heme in a stoichiometry
of 1:2 (heme:protein). Mature HRG-3 is secreted into the worm’s
circulation and taken up by extracellular tissues and developing
oocytes. When hrg-3 null worms are grown under heme limiting
conditions, they show embryonic lethality and delayed growth,
indicating a role for hrg-3 in the distribution of heme from the
intestine during early embryonic and larval development (Chen
et al., 2011).
It was not surprising to discover a mechanism for heme trans-
port along a maternal-to-embryonic axis in C. elegans, as this
animal is a heme auxotroph and thus completely reliant on dietary
heme. Surprisingly, however, a similar pathway was found in the
blood sucking insectR. prolixus, a heme prototroph (Walter-Nuno
et al., 2013). In a single meal, R. prolixus can ingest several times
its own weight in blood. To deal with the oxidative stress associ-
ated with such a massive amount of heme, R. prolixus expresses
a 15 kDa protein termed RHBP (Oliveira et al., 1995). RHBP is
synthesized in the insect’s fat body at all stages of development. It
is secreted into the hemolymph, where it and any heme bound to it
are taken up into developing oocytes via receptor-mediated endo-
cytosis. Interestingly, silencing of RHBP results in a unique form
of embryonic lethality. Eggs laid early during oviposition retain
their characteristic red color and develop normally; however, eggs
laid at the later time are not viable and are pale due to lack of heme
(Walter-Nuno et al., 2013). These eggs showed evidence of fertil-
ization, but no embryo formation. Additionally, analysis of both
heme-dependent and heme-independent mitochondrial enzymes
showed widespread mitochondrial dysfunction in these later eggs
(Walter-Nuno et al., 2013).
Rhodnius eggs require maternal heme because they are inca-
pable of producing sufﬁcient endogenous heme to sustain devel-
opment. The use of RHBP couples the process of ameliorating
heme toxicity in the adult to embryonic development – turning a
liability into an essential asset. Interestingly, the heme delivered to
these eggs is not degraded to release iron (as no heme degradation
products are detected in the eggs) and the heme is incorporated in
toto into embryonic hemoproteins.
EVIDENCE FOR HEME TRANSPORT BETWEEN CELLS AND
TISSUES
While the requirement for intracellular heme trafﬁcking, based
on the understanding of heme chemistry and cell membrane
dynamics, is fairly intuitive and supported by the well-established
paradigm for copper, zinc and iron trafﬁcking pathways, the con-
cept of heme trafﬁcking fromone tissue to another is controversial.
Whymoveheme fromone tissue to another if each cell in anorgan-
ism is capable of synthesizing its own heme? However, there are
several lines to evidence to support the potential existence of these
pathways:
(1) While the bulk of heme imported into the intestine is pur-
ported to be degraded by heme oxygenases and exported as
iron, small amounts of heme have been show to be transported
intact along the basolateral membrane of enterocytes. Studies
in polarizedmonolayers of human enterocyte-like Caco-2 cells
have shown that a portion of heme transported intact across
the basolateral membrane (Uc et al., 2004). Basolateral trans-
port of heme from intestinal cells was also observed in guinea
pigs (Conrad et al., 1966).
(2) Patients suffering acute attacks of porphyrias are administered
heme intravenously as therapeutic treatment. This treatment
results in increased heme-dependent enzyme activities in the
liver, indicating that exogenous heme can be utilized in toto
(Puy et al., 2010).
(3) The existence of widely expressed mammalian plasma mem-
brane heme importers and exporters implies a physiological
role for heme import and export (Quigley et al., 2004; Keel
et al., 2008; Rajagopal et al., 2008) For example, we have dis-
cussed the heme importer Hrg1, which localizes to the plasma
membrane in polarized cells, and is expressed in a number of
tissues including the brain, kidney, heart, skeletal muscle, liver,
lung, placenta, and small intestine. Knockdown of Hrg1 in
zebraﬁsh causes severe anemia, indicating a possible role for
intercellular heme transport during erythropoiesis.
(4) With speciﬁc regards to heme-recycling in macrophages of
the RES, there is evidence that intact heme is exported
from the cells after EP. After phagocytosis of 59Fe-labeled
RBCs, 59Fe-labeled heme was released from J774 mouse
macrophages (Knutson et al., 2005). Additionally, Flcvr-
deleted macrophages showed impaired export of 55Fe-labeled
heme (Keel et al., 2008).
(5) Lastly, while heme synthesis mutants are lethal, these embryos
do survive for several days. For example, mice lacking fer-
rochelatase live beyond E3.5, and zebraﬁsh lacking proto-
porphyrinogen oxidase survive for 35 days post-fertilization
(Magness et al., 2002; Dooley et al., 2008). This implies that
developing embryos can either develop in the absence of
heme or plausibly mobilize heme stores during initial stages
of development, independent of heme synthesis.
The severity of phenotypes associatedwith loss of heme synthe-
sis indicates that intracellular heme trafﬁcking pathways are not
the primary modes to support the heme requirements of animals.
The generation of (a) tissue-speciﬁc heme synthesis knockout ani-
mals; (b) genetic chimeras using in vivo tissue-speciﬁc reporters;
and (c) new modalities of live imaging of heme using label-free
microscopy at the tissue and subcellular level would be greatly
beneﬁcial in determining the capacity for inter- and intra-tissue
heme transport. Ultimately, these pathways may be relevant under
speciﬁc conditions of aberrant iron or RBChomeostasis, or during
pathogenesis. We include in this review a call for further testing
and analysis of these ideas.
CONCLUSION
In this review, we have discussed the following topics:
• The biophysical and physiological need for heme transport
across biological membranes
• A detailed catalog of hemoproteins found in each compart-
ment within a cell
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• The known and putative transport pathways for mobilization
of heme to each subcellular compartment
• The putative pathways underlying physiological processes
where heme transport may be required or beneﬁcial
• Evidence for the possibility of inter-tissue heme transport
We had three aims with this review. First, we intended to
provide a comprehensive outline of the heme requirements in dif-
ferent locations within a cell and deﬁne what is known or remains
unknown regarding how heme is transported to those places.
Though much progress has been made in the past decade, much
remains unknown. The ﬁeld is lacking genetic tools, microscopic
techniques capable of imaging heme in live cells, and subcellular
sensors of heme levels. We hope this review will spur new ideas
and creative thinking regarding how to tackle these questions.
Second, we intended to place what is known about heme trans-
port in the context of physiological processes which are known
to or likely require the mobilization of heme. Again, very lit-
tle is known about heme movement during these events, but we
attempted to outline possible mechanisms and players. We hope
calling attention to these unknowns will impel members of the
ﬁeld to consider them.
Last, we aimed to question the current dogma that heme is not
mobilized from one cell or tissue to other in heme prototrophs.
Much as the homeostasis of biometals and lipids relies on inter-
tissue trafﬁcking pathways, it appears likely that heme utilizes
similar transport routes like iron in the blood of the people, and
it is incumbent upon members of the ﬁeld to determine if this is
indeed so.
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